Emerging diagnostics, therapies and procedures are improving the outlook for patients with colorectal cancer, yet this rapidly changing treatment landscape can be confusing. Similarly, healthcare providers are confounded by high rates of colorectal cancer in patients under the age of 50. The 9th annual colorectal oncology course, held at Marco Island, Florida on October 6-7, 2023, will feature panel discussions and Q&As with noted specialists across surgery, radiation oncology and genomics managing this complex disease.

“This essential update on the latest treatment changes in colorectal cancer will provide a multidisciplinary approach that’s crucial for disease management,” says Alok Khorana, MD, Director, Gastrointestinal Malignancies Program at Cleveland Clinic Cancer Center. “The program also brings focus to diagnosing and treating young-onset colorectal cancer.”

This two-day program is ideal for oncologists, surgeons, radiation oncologists, nurses and other healthcare professionals with an interest in treating patients with colorectal cancer.  “For clinicians who may be too busy to attend large conferences, this national symposium a convenient way to get up to speed on everything that’s new in treating this disease.”

In this in-depth symposium, learners will gain a detailed look at a wide range of topics, including:

• Total neoadjuvant therapy and neoadjuvant chemotherapy
• The role of genomics and circulating tumor DNA in treatment decisions
• Patient case studies
• Management disease recurrence and adverse events

The live event is designated for a maximum of 8.25 American Medical Association PRA Category 1 Credits™ and 8.25 American Nurses Credentialing Center contact hours.

Register now.